Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

VBS Fellows Foray 2020: Cases and Real-World Treatment Strategies – Part 1 – Live

By: Aleksandra V. Rachitskaya, MD; Will Parke, MD; Anton Orlin, MD; Camila Ventura, MD, PhD

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

This CME-accredited program, originally planned for the 2020 VBS Annual Meeting, is now digital! Carefully selected cases will be presented by fellows from around the globe. Retina cases you would not believe! Real-world treatment strategies will be enthusiastically discussed among the esteemed panel members. Audience participation is encouraged!

This truly unique series is designed for fellows, residents, and eye care specialists who recently entered practice and are involved in the management of patients with vitreoretinal disorders.

Expiration Date: Tuesday, May 26, 2020
Release Date: May 20, 2020

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss a wide variety of treatment approaches for both age-related macular degeneration and diabetic eye disease.
  • Develop individualized treatment plans for patients with retina disorders that use a combination of imaging, treat and extend, or treat and observe approaches.
  • Apply case study examples to real-world clinical settings.

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Faculty and Disclosures

VIT BUCKLE SOCIETY MODERATORS:

Anton Orlin, MD

Associate Professor of Ophthalmology
Weill Cornell Medical College
New York, NY

 

D. Wilkin Parke III, MD

VitreoRetinal Surgery, PA
Co-director, Vitreoretinal Surgery Fellowship Program
Minneapolis, MN

 

Aleksandra V. Rachitskaya, MD

Assistant Professor of Ophthalmology
Cole Eye Institute, Cleveland Clinic
Cleveland, OH

 

Camila Ventura, MD, PhD

Department of Ophthalmology
Retina Specialist
Department of Research, Director
Altino Ventura Foundation (FAV)
Hope Eye Hospital
Recife, Pernambuco, Brazil

 

PANELISTS:

Valentina Franco Cárdenas, MD

Medical and Surgical Retina Specialist
Mexico City, Mexico

 

James C. Major Jr MD, PhD, FACS

Retina Consultants of Houston
Assistant Professor
Weill Cornell Medical College
Blanton Eye Institute
Houston Methodist Hospital
Houston, TX

 

Cynthia Qian, MD, FRCSC, DABO

Assistant Professor of Clinical Ophthalmology
Vice President, Canadian Retina Society
Director, Pediatric Retina Service
Director, Retinal Dystrophy Service and the Electrophysiology Laboratories
University of Montreal
Montréal, Québec, Canada

 

Nathan Steinle, MD

California Retina Consultants
Santa Barbara, CA

 

Jeremy Wolfe, MD, MS

Associate Professor of Ophthalmolgy Oakland University William Beaumont School of Medicine
Partner, Associated Retinal Consultants
Co-Director, Vitreoretinal Fellowship Program
Royal Oak, MI

 

FELLOWS

Pablo Chamartin, MD

APEC (Asociación para Evitar la Ceguera en México)

 

David Ta Kim, MD

University of Toronto – St. Michael’s Hospital

 

Idaira Sanchez Santos, MD

APEC (Asociación para Evitar la Ceguera en México)

 

Jay C. Wang, MD

Massachusetts Eye and Ear

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Moderators

Anton Orlin, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, and Carl Zeiss Meditec.

Wilkin Parke III, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Royalties: Vortex Surgical.

Aleksandra V. Rachitskaya, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, and Carl Zeiss Meditec. Speaker’s Bureau: Novartis.

Camila Ventura, MD, PhD has no financial relationships with commercial interests.

 

Panelists

Valentina Franco Cárdenas, MD has no financial relationships with commercial interests.

James C. Major Jr MD, PhD, FACS has no financial relationships with commercial interests.

Cynthia Qian, MD, FRCSC, DABO and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bayer and Novartis.

Nathan Steinle, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Appellis, Genentech, Novartis, Regeneron Pharmaceuticals, and REGENXBIO. Grant/Research Support: Carl Zeiss Meditec, and Ocular Therapeutix. Speaker’s Bureau: Genentech, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Vortex Surgical.

Jeremy Wolfe, MD, MS and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Genentech, and Novartis.  Grant/Research: Genentech, Kodiak, Novartis, and Regeneron Pharmaceuticals. Speaker’s Bureau: Allergan, Genentech, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Vortex Surgical

 

Fellows

Pablo Chamartin, MD; David Ta Kim, MD; Idaira Sanchez Santos, MD; Jay C. Wang, MD; have no financial relationships with commercial interests.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Regeneron Pharmaceuticals or Carl Zeiss Meditec.

Welcome to VBS Fellows Foray 2020: Cases and Real-World Treatment Strategies.

Please click “Begin Program” to open the Zoom session for the live program.

If prompted, please use password: 856502

Begin Program

BackNext